Mednax, Inc. (MD) Accused of Making Misleading Statements

According to the class action complaint, during the class period Mednax, Inc. (MD) touted the sustainability of its business model, which depended upon growth from the acquisition of new practice groups, primarily in anesthesiology. The complaint alleges that in reality, the company's growth was based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections. On July 28, 2017, Mednax surprised the market when it announced it had not acquired any anesthesiology practice groups for that quarter and that the chance for acquiring any more was remote. On this news, Mednax's stock declined by over 15%.

Mednax, Inc. (MD) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies please send us a message via the
Shareholder Information form below.